Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten U Vogel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos One|November 2, 2017
Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strainsIvette A Nuñez, Michael A Carlock, James D Allen, et al.
Journal of Virology|December 26, 2001
Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infectionBianca R Mothé, Helen Horton, Donald K Carter, et al.
Elife|May 28, 2024
The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Preclinical qualification of a new multi-antigen candidate vaccine for metastatic melanomaThorsten U Vogel, Lucian Visan, Belma Ljutic, et al.
Journal of Virology|October 22, 2002
Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?Thorsten U Vogel, Thomas C Friedrich, David H O'Connor, et al.
Journal of Virology|December 3, 2003
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239Thorsten U Vogel, Matthew R Reynolds, Deborah H Fuller, et al.
Journal of Virology|June 20, 2002
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239Helen Horton, Thorsten U Vogel, Donald K Carter, et al.
Vaccine|September 9, 2019
Comparison of adjuvants to optimize influenza neutralizing antibody responsesRebecca S Rudicell, Marie Garinot, Masaru Kanekiyo, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos One|November 2, 2017
Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strainsIvette A Nuñez, Michael A Carlock, James D Allen, et al.
Journal of Virology|December 26, 2001
Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infectionBianca R Mothé, Helen Horton, Donald K Carter, et al.
Elife|May 28, 2024
The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Preclinical qualification of a new multi-antigen candidate vaccine for metastatic melanomaThorsten U Vogel, Lucian Visan, Belma Ljutic, et al.
Journal of Virology|October 22, 2002
Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?Thorsten U Vogel, Thomas C Friedrich, David H O'Connor, et al.
Journal of Virology|December 3, 2003
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239Thorsten U Vogel, Matthew R Reynolds, Deborah H Fuller, et al.
Journal of Virology|June 20, 2002
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239Helen Horton, Thorsten U Vogel, Donald K Carter, et al.
Vaccine|September 9, 2019
Comparison of adjuvants to optimize influenza neutralizing antibody responsesRebecca S Rudicell, Marie Garinot, Masaru Kanekiyo, et al.
Pageof 3